Effects of 3days of citrulline malate supplementation on short-duration repeated sprint running performance in male team sport athletes.

Abstract

Citrulline malate (CM) is purported to be an ergogenic aid during various types of exercise performance. However, the effects of CM on repeated sprint performance (RSP) are under-explored. In a placebo-controlled, double-blind, counterbalanced cross-over design, male university-level team sport athletes (n=13) performed two familiarization trials, after which CM or placebo (PLA) (8×1g tablets each day) were taken on the 2days prior to, and with breakfast on the morning of, each main experimental trial. The main experimental trials employed a RSP protocol consisting of 10 repetitions of 40m maximal shuttle run test (MST) with a 30s interval between the start of each sprint. Sprint times and heart rate were recorded throughout the MST, and blood lactate concentrations were measured before, immediately after, and 5min after completing the MST. CM resulted in better RSP compared to PLA, as indicated by a lower sprint performance decrement (Sdec: CM, 4.68%±1.82% vs. PLA, 6.10%±1.83%; p=0.03; ES=0.77), which was possibly influenced by the fastest sprint time being faster in CM (CM, 8.16±0.34s vs. PLA, 8.29±0.39s; p=0.011; ES=0.34). There were no differences between CM and PLA in average sprint time (p=0.54), slowest sprint time (p=0.48), blood lactate concentrations (p=0.73) or heart rate (p=0.18), nor was there a condition×time interaction effect across the 10 sprints (p=0.166). Three days of CM supplementation (8g daily) attenuated the sprint performance decrement during short-duration high-intensity exercise in the form of running RSP in male university-level team sport athletes.